Editorial
|
| Contact inhibition against senescence |
|
https://doi.org/10.18632/oncotarget.2446
|
| 7212-7213 |
|
| mTORC2 takes the longevity stAGE |
|
https://doi.org/10.18632/oncotarget.2457
|
| 7214-7215 |
News
Reviews
|
| Molecular pathways and targets in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2406
|
| 7217-7259 |
|
| TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis |
|
https://doi.org/10.18632/oncotarget.2428
|
| 7260-7271 |
|
| Altered Mucins MUC Trafficking in Benign and Malignant Conditions |
|
https://doi.org/10.18632/oncotarget.2370
|
| 7272-7284 |
|
| The structural basis for cancer treatment decisions |
|
https://doi.org/10.18632/oncotarget.2439
|
| 7285-7302 |
Priority Research Papers
|
| Acetylationdefective mutants of Pparγ are associated with decreased lipid synthesis in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.2371
|
| 7303-7315 |
|
| AP4 is required for mitogen and cMYCinduced cell cycle progression |
|
https://doi.org/10.18632/oncotarget.2348
|
| 7316-7327 |
|
| Overcoming EMTassociated resistance to anticancer drugs via Src/FAK pathway inhibition |
|
https://doi.org/10.18632/oncotarget.2397
|
| 7328-7341 |
|
| Epigenetic suppression of EGFR signaling in GCIMP+ glioblastomas |
|
https://doi.org/10.18632/oncotarget.2350
|
| 7342-7356 |
Clinical Research Papers
|
| Nuclear Eg5 kinesin spindle protein expression predicts docetaxel response and prostate cancer aggressiveness |
|
https://doi.org/10.18632/oncotarget.1985
|
| 7357-7367 |
|
| Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive Bcell nonhodgkin lymphoma |
|
https://doi.org/10.18632/oncotarget.2255
|
| 7368-7380 |
|
| 18 FDGPET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation |
|
https://doi.org/10.18632/oncotarget.2290
|
| 7381-7391 |
Research Papers
|
| NM23H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment |
|
https://doi.org/10.18632/oncotarget.1912
|
| 7392-7405 |
|
| Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.1558
|
| 7406-7419 |
|
| Applicability of the methylated CpG sites of paired box 5 PAX5 promoter for prediction the prognosis of gastric cancer |
|
https://doi.org/10.18632/oncotarget.1973
|
| 7420-7430 |
|
| Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROSdependent synergism and signaling crosstalk |
|
https://doi.org/10.18632/oncotarget.2008
|
| 7431-7445 |
|
| TRIM8 antiproliferative action against chemoresistant renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2081
|
| 7446-7457 |
|
| High mobility group Box1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression |
|
https://doi.org/10.18632/oncotarget.2150
|
| 7458-7470 |
|
| Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.2166
|
| 7471-7485 |
|
| EMT and EGFR in CTCs cytokeratin negative nonmetastatic breast cancer |
|
https://doi.org/10.18632/oncotarget.2217
|
| 7486-7497 |
|
| Aurora kinase a suppresses metabolic stressinduced autophagic cell death by activating mTOR signaling in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.2241
|
| 7498-7511 |
|
| Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair |
|
https://doi.org/10.18632/oncotarget.2258
|
| 7512-7524 |
|
| Beclin1independent autophagy positively regulates internal ribosomal entry sitedependent translation of hypoxiainducible factor 1α under nutrient deprivation |
|
https://doi.org/10.18632/oncotarget.2265
|
| 7525-7539 |
|
| Arraybased genomewide RNAi screening to identify shRNAs that enhance p53related apoptosis in human cancer cells |
|
https://doi.org/10.18632/oncotarget.2272
|
| 7540-7548 |
|
| Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NFκB signaling |
|
https://doi.org/10.18632/oncotarget.2273
|
| 7549-7562 |
|
| βTrCP controls the lysosomemediated degradation of CDK1 whose accumulation correlates with tumor malignancy |
|
https://doi.org/10.18632/oncotarget.2274
|
| 7563-7574 |
|
| Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells |
|
https://doi.org/10.18632/oncotarget.2243
|
| 7575-7588 |
|
| Osteoblastderived WISP1 increases VCAM1 expression and enhances prostate cancer metastasis by downregulating miR126 |
|
https://doi.org/10.18632/oncotarget.2280
|
| 7589-7598 |
|
| MicroRNA145 targets MUC13 and suppresses growth and invasion of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.2281
|
| 7599-7609 |
|
| Silencing of miRNA148a by hypermethylation activates the integrinmediated signaling pathway in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.2282
|
| 7610-7624 |
|
| NMycinduced upregulation of TRPM6/TRPM7 channels promotes neuroblastoma cell proliferation |
|
https://doi.org/10.18632/oncotarget.2283
|
| 7625-7634 |
|
| Selective targeting of KRASMutant cells by miR126 through repression of multiple genes essential for the survival of KRASMutant cells |
|
https://doi.org/10.18632/oncotarget.2284
|
| 7635-7650 |
|
| MicroRNAmediated downregulation of NKG2D ligands contributes to glioma immune escape |
|
https://doi.org/10.18632/oncotarget.2287
|
| 7651-7662 |
|
| CLDN3 inhibits cancer aggressiveness via WntEMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2288
|
| 7663-7676 |
|
| A central role for TRPS1 in the control of cell cycle and cancer development |
|
https://doi.org/10.18632/oncotarget.2291
|
| 7677-7690 |
|
| Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI73 |
|
https://doi.org/10.18632/oncotarget.2296
|
| 7691-7704 |
|
| Expression and functions of galectin7 in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2299
|
| 7705-7721 |
|
| Metabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway resulting in increased antioxidant defense |
|
https://doi.org/10.18632/oncotarget.2300
|
| 7722-7733 |
|
| Amphipathic tailanchoring peptide is a promising therapeutic agent for prostate cancer treatment |
|
https://doi.org/10.18632/oncotarget.2301
|
| 7734-7747 |
|
| The microRNA23b/27b/241 cluster is a disease progression marker and tumor suppressor in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2294
|
| 7748-7759 |
|
| Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR494 |
|
https://doi.org/10.18632/oncotarget.2305
|
| 7760-7775 |
|
| Annexin A4 induces platinum resistance in a chlorideand calciumdependent manner |
|
https://doi.org/10.18632/oncotarget.2306
|
| 7776-7787 |
|
| The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination |
|
https://doi.org/10.18632/oncotarget.2307
|
| 7788-7804 |
|
| Clusterin inhibition using OGX011 synergistically enhances zoledronic acid activity in osteosarcoma |
|
https://doi.org/10.18632/oncotarget.2308
|
| 7805-7819 |
|
| Neddylation pathway is upregulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target |
|
https://doi.org/10.18632/oncotarget.2309
|
| 7820-7832 |
|
| Coordination of cell cycle migration and stem celllike activity in breast cancer |
|
https://doi.org/10.18632/oncotarget.2312
|
| 7833-7842 |
|
| A highly efficient tumorinfiltrating MDSC differentiation system for discovery of antineoplastic targets which circumvents the need for tumor establishment in mice |
|
https://doi.org/10.18632/oncotarget.2279
|
| 7843-7857 |
|
| ÂIntegrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer |
|
https://doi.org/10.18632/oncotarget.2313
|
| 7858-7869 |
|
| Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2dependent ubiquitin proteasome pathway in TGFβ receptor degradation |
|
https://doi.org/10.18632/oncotarget.2317
|
| 7870-7885 |
|
| Assessment of the effect of sphingosine kinase inhibitors on apoptosisunfolded protein response and autophagy of Tcell acute lymphoblastic leukemia cells; indications for novel therapeutics |
|
https://doi.org/10.18632/oncotarget.2318
|
| 7886-7901 |
|
| miR200c overexpression is associated with better efficacy of EGFRTKIs in nonsmall cell lung cancer patients with EGFR wildtype |
|
https://doi.org/10.18632/oncotarget.2302
|
| 7902-7916 |
|
| Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.1421
|
| 7917-7935 |
|
| Mutant NRASQ61 shares signaling similarities across various cancer types – potential implications for future therapies |
|
https://doi.org/10.18632/oncotarget.2326
|
| 7936-7944 |
|
| FAK Inhibition with Small Molecule Inhibitor Y15 Decreases Viability Clonogenicity and Cell Attachment in Thyroid Cancer Cell Lines and Synergizes with Targeted Therapeutics |
|
https://doi.org/10.18632/oncotarget.2381
|
| 7945-7959 |
|
| Mutations in CIC and IDH1 cooperatively regulate 2hydroxyglutarate levels and cell clonogenicity |
|
https://doi.org/10.18632/oncotarget.2401
|
| 7960-7979 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
